Royal Bank of Canada’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-361
| Closed | -$27K | – | 7642 |
|
|
2022
Q2 | $27K | Sell |
361
-2,808
| -89% | -$210K | ﹤0.01% | 5519 |
|
|
2022
Q1 | $85K | Sell |
3,169
-6,327
| -67% | -$170K | ﹤0.01% | 5294 |
|
|
2021
Q4 | $453K | Buy |
9,496
+7,398
| +353% | +$353K | ﹤0.01% | 4062 |
|
|
2021
Q3 | $139K | Sell |
2,098
-14,649
| -87% | -$971K | ﹤0.01% | 4969 |
|
|
2021
Q2 | $1.31M | Sell |
16,747
-34,546
| -67% | -$2.7M | ﹤0.01% | 3054 |
|
|
2021
Q1 | $4.85M | Sell |
51,293
-3,001
| -6% | -$284K | ﹤0.01% | 1984 |
|
|
2020
Q4 | $6.62M | Sell |
54,294
-39
| -0.1% | -$4.75K | ﹤0.01% | 1725 |
|
|
2020
Q3 | $4.75M | Buy |
54,333
+29,844
| +122% | +$2.61M | ﹤0.01% | 1772 |
|
|
2020
Q2 | $1.58M | Buy |
24,489
+422
| +2% | +$27.2K | ﹤0.01% | 2455 |
|
|
2020
Q1 | $1.07M | Buy |
24,067
+22,290
| +1,254% | +$995K | ﹤0.01% | 2594 |
|
|
2019
Q4 | $111K | Buy |
+1,777
| New | +$111K | ﹤0.01% | 4450 |
|
|
2019
Q3 | – | Sell |
-112
| Closed | -$5K | – | 6292 |
|
|
2019
Q2 | $5K | Buy |
+112
| New | +$5K | ﹤0.01% | 5431 |
|